IBA Secures $90M+ Deal with Duke for Two Proton Therapy Systems
Event summary
- IBA SA signs contract with Duke University Health System for two Proteus®ONE proton therapy systems, valued at $45–55M each.
- Installation at Duke Proton Center in Durham, NC, with treatments expected to begin in 2029.
- Deal includes long-term operation and maintenance services contract.
- Systems configured for maximum clinical availability and operational flexibility.
The big picture
IBA's deal with Duke University Health System underscores the growing demand for advanced proton therapy solutions in academic medical centers. The $90M+ contract highlights the strategic importance of compact, adaptable proton therapy systems in expanding access to precision cancer treatment. This partnership positions IBA to strengthen its leadership in the proton therapy market, particularly in the U.S., where academic medical centers are increasingly adopting cutting-edge radiation therapy technologies.
What we're watching
- Market Expansion
- Whether IBA can leverage this deal to establish Duke as a regional reference center for proton therapy.
- Technological Integration
- The pace at which Proteus®ONE systems will incorporate future technological advancements.
- Operational Efficiency
- How the side-by-side configuration will impact clinical availability and patient treatment efficiency.